C12N 2501/2335
Interleukin-35
Official title: Interleukin-35 (IL-35)
C12N2501/2335 (Interleukin-35) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 5
- Assignees
- 3
- Inventors
- 8
- Latest grant
- 25 Apr 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Method of producing tumor-reactive t cell composition using modulatory agents2 Feb 2023US 2023/0032934 A1Myst Therapeutics, LLC
- New use28 Nov 2019US 2019/0359939 A1
- Methods of producing and using regulatory b-cells23 Apr 2015US 2015/0110737 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
- Compositions and methods for generating interleukin-35-induced regulatory t cells27 Nov 2014US 2014/0348809 A1St. Jude Children?S Research Hospital
- Compositions and methods for generating interleukin-35-induced regulatory t cells8 Mar 2012US 2012/0058096 A1St. Jude Children?S Research Hospital
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.